JAMA Oncology shared a post on X:
“A deep learning AI model showed improved accuracy over existing biomarkers in predicting immune checkpoint inhibitor treatment response in advanced non-small cell lung cancer patients.”
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer
Authors: Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, Joao V. Alessi, Alessio Cortellini, Fabrizio Citarella, Lorenzo Nibid, Giuseppe Perrone, Elio Adib, Claudia A. M. Fulgenzi, Cassio Murilo Hidalgo Filho, Alessandro Di Federico, Falah Jabar, Sayed Hashemi, Ilias Houda, Elin Richardsen, Lill-Tove Rasmussen Busund, Tom Donnem, Idris Bahce, David J. Pinato, Åslaug Helland, Lynette M. Sholl, Mark M. Awad, and David J. Kwiatkowski.
